Search clinical trials for: MCLA-145
Total 388 results
-
Merus N.V.Incyte CorporationRecruitingAdvanced Cancer | Solid Tumor, Adult | B-cell Lymphoma, AdultUnited States, Spain, Belgium, Netherlands
-
Betta Pharmaceuticals Co., Ltd.RecruitingHead and Neck Cancer | Colorectal Cancer | Non-Small Cell Lung Cancer | Solid TumorChina
-
SecuraBioCompleted
-
SecuraBioCompletedAsthmaGermany, United Kingdom
-
SecuraBioCompletedHepatic ImpairmentUnited States
-
Jena University HospitalCompletedEffectiveness and Safety of the Seldinger Wire Technique Using a 145 cm Guidewire With the Modified Seldinger Technique Using a 70 cm GuidewireGermany
-
SecuraBioTerminatedHematologic MalignanciesUnited States
-
SecuraBioCompletedIndolent Non-Hodgkin LymphomaBelgium, France, Italy, Spain, Canada, United States, Bulgaria, United Kingdom, Hungary, Georgia, Belarus, Czechia
-
Merus N.V.RecruitingNSCLC Harboring NRG1 Fusion | Solid Tumours Harboring NRG1 Fusion | Pancreatic Cancer Harboring NRG1 Fusion | NRG1 FusionSpain, France, Israel, Belgium, Denmark, United States, Korea, Republic of, Japan, Germany, Netherlands, Austria, Canada, Italy, Norway, Singapore, Sweden, Taiwan, United Kingdom
-
EnsomaCompletedHealthy | Renal InsufficiencyUnited States
-
SecuraBioCompletedHematologic MalignancyUnited States, Italy
-
Merus N.V.AvailableRenal Cell Carcinoma | Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Prostate Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Solid Tumor, Unspecified, Adult | Unknown Primary Tumors | NRG1 Fusion
-
Iovance Biotherapeutics, Inc.CompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
AbbVieInfinity Pharmaceuticals, Inc.Completed
-
Merus N.V.Chiltern International Inc.; Q2 Solutions; Oncology Therapeutic Development (OTD) and other collaboratorsRecruitingGastric Cancer | Colorectal Cancer | NSCLC | Head and Neck Squamous Cell Carcinoma | HNSCC | Advanced/Metastatic Solid Tumors | Gastroesophageal-junction CancerUnited States, Spain, Belgium, France, Netherlands, United Kingdom
-
Ensomabluebird bioTerminatedSickle Cell DiseaseUnited States
-
Betta Pharmaceuticals Co., Ltd.Not yet recruitingNon-Small Cell Lung Cancer、EGFR Sensitive MutationChina
-
Merus N.V.Active, not recruitingAcute Myeloid Leukemia | Acute Myelogenous LeukemiaUnited States, Italy, Netherlands, Belgium, France
-
GE HealthcareMedpace, Inc.; Biomedical Systems; i3 Statprobe; Rules-Based Medicine, Inc.CompletedDiabete Mellitus | Congestive Heart Failure | Chronic Renal InsufficiencyUnited States
-
M.D. Anderson Cancer CenterInfinity Pharmaceuticals, Inc.Withdrawn
-
GE HealthcareMedpace, Inc.; i3 StatprobeCompleted
-
Memorial Sloan Kettering Cancer CenterSynta Pharmaceuticals Corp.Completed
-
BiocadCompletedMelanomaRussian Federation
-
Merus N.V.RecruitingMetastatic Castration-resistant Prostate Cancer | NSCLC Harboring NRG1 FusionUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Laboratorios Sophia S.A de C.V.Completed
-
Yaakov NahmiasRambam Health Care Campus; Nazareth Hospital; Barzilai Medical CenterRecruitingRespiratory Distress Syndrome | SARS-CoV-2 Infection | Corona Virus Disease (COVID-19)Israel
-
SecuraBioCompletedHealthy VolunteersNetherlands
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingPediatric or Young Adult Cancer SurvivorsUnited States
-
University of PadovaAzienda Ospedaliera di PadovaCompletedDiabetes | Diabetic RetinopathyItaly
-
I.M. Sechenov First Moscow State Medical UniversityRecruitingNephrolithiasis | Urolithiasis | Kidney StoneRussian Federation
-
ARCIM Institute Academic Research in Complementary...University Hospital TuebingenCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedCaregiver BurdenUnited States
-
AbbottCompletedDyslipidemiaArgentina, Czech Republic, Germany, Mexico, Poland, Romania, Russian Federation
-
Pauls Stradins Clinical University HospitalRecruiting
-
Dana-Farber Cancer InstituteSecura Bio, Inc.RecruitingChronic Lymphocytic Leukemia | Richter SyndromeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Iovance Biotherapeutics, Inc.Active, not recruitingMalignant Solid Neoplasm | Soft Tissue Sarcoma | Recurrent Ovarian Carcinoma | Triple Negative Breast Cancer | Recurrent Osteosarcoma | Refractory Osteosarcoma | Bone Sarcoma | Giant Cell Tumor of Bone | Ovarian Carcinosarcoma | Platinum-Resistant Ovarian Carcinoma | Dedifferentiated Chondrosarcoma | Malignancy... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterTerminated
-
Merus N.V.RecruitingGastric Cancer | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma | Non-Small Cell Lung Cancer MetastaticUnited States, Spain, France, Italy, Netherlands, Belgium, Korea, Republic of, Germany, Singapore
-
Wake Forest University Health SciencesNational Institute of Neurological Disorders and Stroke (NINDS)Completed
-
Wake Forest University Health SciencesNational Institute of Neurological Disorders and Stroke (NINDS)Completed
-
Merck Sharp & Dohme LLCCompleted
-
Yale UniversityIovance Biotherapeutics, Inc.CompletedMetastatic Triple Negative Breast CancerUnited States
-
Iovance Biotherapeutics, Inc.RecruitingCervical CarcinomaUnited States, Spain, United Kingdom, Germany, France, Italy, Netherlands, Switzerland
-
Reham HassanCompletedEffects of the ElementsEgypt
-
Parker Research InstituteVIA University College; University of Southern DenmarkCompletedChronic Conditions, MultipleDenmark
-
Cairo UniversityCompleted
-
Zeynep Kamil Maternity and Pediatric Research and...CompletedEarly Amniotomy, Unfavorable CervixTurkey
-
AmgenCompletedMixed Dyslipidemia | Primary HypercholesterolemiaUnited States, Canada